CPER Research Seminar
Developing synergies at regional level and promoting collaborative research
![[Translate to English:] Photo de Nathalie Mielcarek](/fileadmin/_processed_/0/0/csm_Journe__e_inter-cper_Nathalie_8915e85a1d.jpg)
[Translate to English:] Nathalie Mielcarek (Inserm)
![[Translate to English:] Photo de Nathalie Mielcarek, Céline Miroux, Benoit Deprez et Anne-Sophie Yribarren](/fileadmin/_processed_/8/c/csm_Journe__e_inter-cper_dd5a0aa61b.jpg)
[Translate to English:] Nathalie Mielcarek (Inserm), Céline Miroux (Région Hauts-de-France), Benoit Deprez (Université de Lille) et Anne-Sophie Yribarren (Université de Lille)
10 December 2025, at the Hauts-de-France Regional Council
🔎 A major highlight for the Resist-omics CPER team, which was able to present the project’s findings and exchange views with the 15 other CPERs in the Hauts-de-France region.
🩺🦠 On the theme of health, drawing on expertise at the intersection of inflammatory and infectious diseases and drug design technologies, Nathalie Mielcarek, project coordinator alongside David Launay and Benoit Deprez, presented a progress report highlighting significant advances.
➤ 12 scientific projects from the INFINITE lab – Lille Institute for Translational Research in Inflammation, the Lille Centre for Infection and Immunity (CIIL) and the Pasteur Institute of Lille
➤ The acquisition of breakthrough technologies within the Lille health biology platforms UMS_PLBS
➤ The success of a conference grant to support our researchers at major national and international conferences (Axelle Grandé, Amine Pochet, Inès Leleu, Aurore Collet, Mathieu Gissot, Majda Hachmi, Olivier Molendi-Coste, Margot Frider-Gillet, Tanguy Villeval)
➤And major leverage effects, particularly in 2025 with the PEPR Inflammation programme (David Launay) and the France Vaccins initiative (Nathalie Mielcarek)
You can view the detailed programme for the day (PDF, 242 KB, in French).
